Extracellular NAD+: A danger signal hindering regulatory T cells

Microbes and Infection

Volumn 14, Issue 14, 2012, Pages 1284-1292

  Adriouch, Sahil ^a,b   Haag, Friedrich ^c   Boyer, Olivier ^a,b   Seman, Michel ^a,d   Koch Nolte, Friedrich ^c  

^a INSERM   (France)

^b UNIVERSITY OF ROUEN   (France)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

ATP; Danger signals; NAD; P2X7; Tregs

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CRYOPYRIN; L SELECTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y11 RECEPTOR; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; DENDRITIC CELL; ENZYME DEGRADATION; HUMAN; LYMPHOCYTE FUNCTION; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; CELL DEATH; EXTRACELLULAR SPACE; HUMANS; NAD; T-LYMPHOCYTES, REGULATORY;

EID: 84870241830     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.05.011     Document Type: Article

References (70)

1. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
2. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.
3. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat. Immunol. 2007, 8:11-13.
4. Yang D., Postnikov Y.V., Li Y., Tewary P., de la Rosa G., Wei F., Klinman D., Gioannini T., Weiss J.P., Furusawa T., Bustin M., Oppenheim J.J. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J. Exp. Med. 2012, 209:157-171.
5. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
6. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22:5551-5560.
7. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3:995-1001.
8. Vande Walle L., Kanneganti T.D., Lamkanfi M. HMGB1 release by inflammasomes. Virulence 2011, 2:162-165.
9. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., Yagita H., Ishii N., Evans R., Honda K., Takeda K. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008, 455:808-812.
10. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., Vermaelen K., Panaretakis T., Mignot G., Ullrich E., Perfettini J.L., Schlemmer F., Tasdemir E., Uhl M., Genin P., Civas A., Ryffel B., Kanellopoulos J., Tschopp J., Andre F., Lidereau R., McLaughlin N.M., Haynes N.M., Smyth M.J., Kroemer G., Zitvogel L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 2009, 15:1170-1178.
11. McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., Waterhouse C.C., Beck P.L., Muruve D.A., Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
12. Trautmann A. Extracellular ATP in the immune system: more than just a "danger signal". Sci. Signal. 2009, 2:pe6.
13. Wilhelm K., Ganesan J., Muller T., Durr C., Grimm M., Beilhack A., Krempl C.D., Sorichter S., Gerlach U.V., Juttner E., Zerweck A., Gartner F., Pellegatti P., Di Virgilio F., Ferrari D., Kambham N., Fisch P., Finke J., Idzko M., Zeiser R. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med. 2010, 16:1434-1438.
14. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., Park D., Woodson R.I., Ostankovich M., Sharma P., Lysiak J.J., Harden T.K., Leitinger N., Ravichandran K.S. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
15. + shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J. Exp. Med. 2010, 207:2561-2568.
16. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., Isakson B.E., Bayliss D.A., Ravichandran K.S. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
17. Woehrle T., Yip L., Elkhal A., Sumi Y., Chen Y., Yao Y., Insel P.A., Junger W.G. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 2010, 116:3475-3484.
18. +-dependent signalling. FEBS Lett. 2011, 585:1651-1656.
19. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
20. Burnstock G., Verkhratsky A. Evolutionary origins of the purinergic signalling system. Acta Physiol. 2009, 195:415-447.
21. Bours M.J., Swennen E.L., Di Virgilio F., Cronstein B.N., Dagnelie P.C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 2006, 112:358-404.
22. Burnstock G., Kennedy C. P2X receptors in health and disease. Adv. Pharmacol. 2011, 61:333-372.
23. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 2006, 58:58-86.
24. Khakh B.S., North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532.
25. Kawate T., Michel J.C., Birdsong W.T., Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009, 460:592-598.
26. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol. Sci. 2007, 28:465-472.
27. Haag F., Adriouch S., Brass A., Jung C., Moller S., Scheuplein F., Bannas P., Seman M., Koch-Nolte F., Extracellular N.A.D. ATP: partners in immune cell modulation. Purinergic Signal. 2007, 3:71-81.
28. Junger W.G. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 2011, 11:201-212.
29. Zeiser R., Penack O., Holler E., Idzko M. Danger signals activating innate immunity in graft-versus-host disease. J. Mol. Med. (Berlin) 2011, 89:833-845.
30. Adriouch S., Scheuplein F., Bahring R., Seman M., Boyer O., Koch-Nolte F., Haag F. Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7. Purinergic Signal. 2009, 5:151-161.
31. Sluyter R., Stokes L. Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 2011, 5:41-54.
32. Wiley J.S., Sluyter R., Gu B.J., Stokes L., Fuller S.J. The human P2X7 receptor and its role in innate immunity. Tissue Antigens 2011, 78:321-332.
33. Adriouch S., Dox C., Welge V., Seman M., Koch-Nolte F., Haag F. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 2002, 169:4108-4112.
34. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 2011, 11:213-220.
35. Yu H.B., Finlay B.B. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 2008, 4:198-208.
36. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., Panther E., Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 2006, 176:3877-3883.
37. + is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J. Biol. Chem. 2006, 281:31419-31429.
38. Koch-Nolte F., Adriouch S., Bannas P., Krebs C., Scheuplein F., Seman M., Haag F. ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells. Ann. Med. 2006, 38:188-199.
39. Laing S., Unger M., Koch-Nolte F., Haag F. ADP-ribosylation of arginine. Amino Acids 2011, 41:257-269.
40. Seman M., Adriouch S., Haag F., Koch-Nolte F. Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr. Med. Chem. 2004, 11:857-872.
41. Adriouch S., Ohlrogge W., Haag F., Koch-Nolte F., Seman M. Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl)transferase 2 and a downstream effector. J. Immunol. 2001, 167:196-203.
42. Bannas P., Adriouch S., Kahl S., Braasch F., Haag F., Koch-Nolte F. Activity and specificity of toxin-related mouse T cell ecto-ADP-ribosyltransferase ART2.2 depends on its association with lipid rafts. Blood 2005, 105:3663-3670.
43. Seman M., Adriouch S., Scheuplein F., Krebs C., Freese D., Glowacki G., Deterre P., Haag F., Koch-Nolte F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003, 19:571-582.
44. Adriouch S., Bannas P., Schwarz N., Fliegert R., Guse A.H., Seman M., Haag F., Koch-Nolte F. ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. FASEB J. 2008, 22:861-869.
45. + and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. J. Immunol. 2009, 182:2898-2908.
46. Kahl S., Nissen M., Girisch R., Duffy T., Leiter E.H., Haag F., Koch-Nolte F. Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation. J. Immunol. 2000, 165:4463-4469.
47. + released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J. Immunol. 2007, 179:186-194.
48. Koch-Nolte F., Reyelt J., Schossow B., Schwarz N., Scheuplein F., Rothenburg S., Haag F., Alzogaray V., Cauerhff A., Goldbaum F.A. Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo. FASEB J. 2007, 21:3490-3498.
49. Wesolowski J., Alzogaray V., Reyelt J., Unger M., Juarez K., Urrutia M., Cauerhff A., Danquah W., Rissiek B., Scheuplein F., Schwarz N., Adriouch S., Boyer O., Seman M., Licea A., Serreze D.V., Goldbaum F.A., Haag F., Koch-Nolte F. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 2009, 198:157-174.
50. Davies C.A., Perrett D., Zhang Z., Nielsen B.R., Blake D.R., Winyard P.G. Simultaneous analysis of nitrite, nitrate and the nicotinamide nucleotides by capillary electrophoresis: application to biochemical studies and human extracellular fluids. Electrophoresis 1999, 20:2111-2117.
51. Pellegatti P., Raffaghello L., Bianchi G., Piccardi F., Pistoia V., Di Virgilio F. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 2008, 3:e2599.
52. Garavaglia S., Bruzzone S., Cassani C., Canella L., Allegrone G., Sturla L., Mannino E., Millo E., De Flora A., Rizzi M. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem. J. 2012, 441:131-141.
53. Krebs C., Adriouch S., Braasch F., Koestner W., Leiter E.H., Seman M., Lund F.E., Oppenheimer N., Haag F., Koch-Nolte F. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J. Immunol. 2005, 174:3298-3305.
54. Partida-Sanchez S., Cockayne D.A., Monard S., Jacobson E.L., Oppenheimer N., Garvy B., Kusser K., Goodrich S., Howard M., Harmsen A., Randall T.D., Lund F.E. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 2001, 7:1209-1216.
55. Partida-Sanchez S., Gasser A., Fliegert R., Siebrands C.C., Dammermann W., Shi G., Mousseau B.J., Sumoza-Toledo A., Bhagat H., Walseth T.F., Guse A.H., Lund F.E. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. J. Immunol. 2007, 179:7827-7839.
56. Sitkovsky M., Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 2005, 5:712-721.
57. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
58. Chen Y., Corriden R., Inoue Y., Yip L., Hashiguchi N., Zinkernagel A., Nizet V., Insel P.A., Junger W.G. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006, 314:1792-1795.
59. Chen Y., Yao Y., Sumi Y., Li A., To U.K., Elkhal A., Inoue Y., Woehrle T., Zhang Q., Hauser C., Junger W.G. Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci. Signal. 2010, 3:ra45.
60. Vaughan K.R., Stokes L., Prince L.R., Marriott H.M., Meis S., Kassack M.U., Bingle C.D., Sabroe I., Surprenant A., Whyte M.K. Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J. Immunol. 2007, 179:8544-8553.
61. Praetorius H.A., Leipziger J. ATP release from non-excitable cells. Purinergic Signal. 2009, 5:433-446.
62. Franchi L., Eigenbrod T., Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009, 183:792-796.
63. MacKenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001, 15:825-835.
64. Schenk U., Westendorf A.M., Radaelli E., Casati A., Ferro M., Fumagalli M., Verderio C., Buer J., Scanziani E., Grassi F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal. 2008, 1:ra6.
65. Schenk U., Frascoli M., Proietti M., Geffers R., Traggiai E., Buer J., Ricordi C., Westendorf A.M., Grassi F. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal. 2011, 4:ra12.
66. Schwarz N., Fliegert R., Adriouch S., Seman M., Guse A.H., Haag F., Koch-Nolte F. Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal. 2009, 5:139-149.
67. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
68. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 2007, 7:875-888.
69. Pelegrin P., Barroso-Gutierrez C., Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J. Immunol. 2008, 180:7147-7157.
70. Qu Y., Misaghi S., Newton K., Gilmour L.L., Louie S., Cupp J.E., Dubyak G.R., Hackos D., Dixit V.M. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 2011, 186:6553-6561.